Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis

Pulmonary alveolar proteinosis (PAP) is a syndrome of reduced GM-CSF-dependent, macrophage-mediated surfactant clearance, dysfunctional foamy alveolar macrophages, alveolar surfactant accumulation, and hypoxemic respiratory failure for which the pathogenetic mechanism is unknown. Here, we examine th...

Descripción completa

Detalles Bibliográficos
Autores principales: McCarthy, Cormac, Lee, Elinor, Bridges, James P., Sallese, Anthony, Suzuki, Takuji, Woods, Jason C., Bartholmai, Brian J., Wang, Tisha, Chalk, Claudia, Carey, Brenna C., Arumugam, Paritha, Shima, Kenjiro, Tarling, Elizabeth J., Trapnell, Bruce C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081448/
https://www.ncbi.nlm.nih.gov/pubmed/30087322
http://dx.doi.org/10.1038/s41467-018-05491-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081448/
https://www.ncbi.nlm.nih.gov/pubmed/30087322
http://dx.doi.org/10.1038/s41467-018-05491-z

Ejemplares similares